Media Partner

Information for Media Partners

International Journal of Drug Regulatory Affairs (IJDRA) is a broad-based journal giving leading international coverage of all aspects of Pharmaceutical Sciences. It publishes high quality original research & reviews. By advertising in IJDRA, you can reach the targeted audiences worldwide. Your product information disseminates internationally with comparatively low cost budget.

Readership

Regulatory Affairs professionals /Scholars, Patent agents, IPR / F&D / R&D professionals, Pharmacologists; toxicologists; Pharmaceutical researchers; Pharmacists; Clinicians, Analysts, etc.

SR.NO.

EVENT DETAILS

POSTER

1.         

Company: UBM India Pvt. Ltd., Andheri (E), Mumbai, India

Event: *7th Annual Global Pharma Regulatory Summit 2018*

Venue: Berlin, Germany

Description: To bridge the gap between external requirements and internal obligations, CPhI India brings to you the 7th Annual Global Pharma Regulatory Summit 2018 scheduled on 30th May, 31st May and 1st June in Mumbai focusing on the clarification and interpretation of the most critical regulatory guidelines established by CSDCO, FDA, EMA, PMDA, Africa and CFDA

Event website: http://www.pharmaregulationindia.com/Media-Partners.aspx

E-mail: jyoti.jeswani@ubm.com

Contact: +91 70453 50749 (Jyoti Jeswani)

2.         

Company: marcus evans

Event: TMF and Clinical Operations Quality Excellence, 19-21 March 2018

Venue: Berlin, Germany

Description: This marcus evans conference will help clinical operations and documentation professionals to develop better practice and methods to improve safety and performance in clinical trials system while supporting more efficient inspection readiness.

Event website: https://goo.gl/mz1TWC

E-mail: melinih@marcusevanscy.com

Contact: MeliniHadjitheori, +357 22849308

3.        

Company: ExL Events

Event: *eRegulatory Submissions Summit*

Description: Taking place July 10-11 in Philadelphia, PA, ExL Events’ eRegulatory Submissions Summit will feature in-depth discussions about best practices for the electronic submissions process and protocols for IDMP, RIMS, global and regulatory submissions. Attendees will hear obstacles submitters encounter during the preparation, filing and management of regulatory submissions and ways that industry leaders are overcoming those challenges to deliver a successful electronic submission.

Event website: http://exlevents.com/eregulatory-submissions-summit/

Emailkosmulski@exlevents.com

Contact: +1-917-242-3897 (Kelly Osmulski)

 

4.        

Company: SELECT BIOSCIENCES INDIA (SELECTBIO)

Event: *Novel Formulation Strategies*

Description:  This event is Scheduled for April 12-13, 2018 in Mumbai. This event will include discussions by Pharma Industry Experts covering issues like Solubility & Oral Bioavailability Enhancement, Modified Release Formulations, Difficult to Formulate FDC, Water Insoluble drugs and 505(b)2 – Innovations for US market. The organizers envisage to bring more and more overseas and industry scientists as speakers.

Event website:http://selectbiosciences.com/conferences/index.aspx?conf=NFS18&se=india

Emailf.zainab@selectbio.in, mjsingh@selectbio.in

Contact: +91 76961 25050 (Farheen Zainab), +91 76962 25050 (Maninderjit Singh)

 

5.        

Company: COMPLIANCE TRAININGS

Event: Computer System Validation (CSV), Data Integrity and 21 CFR Part 11 Compliance

Description:  This event is Scheduled for August 9-10, 2018 in GOA & August 23-24, 2018 Ahmedabad.

This new 2-day Seminar on Computer Systems Validation will explore proven techniques for reducing costs associated with implementing, using, & maintaining computer systems in regulated environments. The FDA performs GxP & Part 11 inspections, with an updated Annex 11 regulation, & companies must update their systems and processes to maintain compliance.

You will get a full understanding of how to perform Risk Assessment as part of the step-by-step risk-based approach to computer system validation. This distinct approach will help minimize project time. You can ensure compliance with QA, FDA, and clients.

Event website: http://compliancetrainings.in

Emailnilotpal.p@compliancetrainings.in, info@compliancetrainings.in

Contact: +91 8867363146 (Nilotpal) / 8041700521

 

Advertisement Policy:

While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.

This Journal carries an advertisement, which generates income, but journal not be dominated by advertisements, and advertising must not be allowed to influence editorial decisions.

Journal follows advertising policies as per International Committee of Medical Journal Editors (ICMJE).

Advertising and Special Services Contact Information:

Dr. Jitendra Badjatya
Editor-In-Chief
Phone: +91-7096160846
Email: editorijdra@gmail.com